IN2013MU03765A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03765A
IN2013MU03765A IN3765MU2013A IN2013MU03765A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A IN 3765MU2013 A IN3765MU2013 A IN 3765MU2013A IN 2013MU03765 A IN2013MU03765 A IN 2013MU03765A
Authority
IN
India
Prior art keywords
atorvastatin calcium
compositions
density lipoprotein
lipoprotein cholesterol
faster
Prior art date
Application number
Inventor
Gayatri Chhaganbhai Patel
Manali Manubhai Malaviya
Akash Rajendrakumar Patel
Brijesh Vallabhbhai Navadiya
Original Assignee
Charotar University Of Science & Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charotar University Of Science & Technology filed Critical Charotar University Of Science & Technology
Priority to IN3765MU2013 priority Critical patent/IN2013MU03765A/en
Publication of IN2013MU03765A publication Critical patent/IN2013MU03765A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Abstract Solubilizing Compositions of Atorvastatin Calcium The present invention discloses solubilizing compositions of atorvastatin calcium which decrease low-density lipoprotein cholesterol (LDL-C) and increase high-density lipoprotein cholesterol (HDL-C). A pharmaceutical formulation of statin comprises of atorvastatin calcium, a non-aqueous vehicle, a binding agent, pharmaceutically acceptable excipients and an antioxidant. It reduces the risk for coronary heart diseases. It exerts faster dissolution in gastric fluid and leads to faster absorption which minimizes acid degradation of drug in the stomach. The compositions are formulated in the form of tablets and capsules.
IN3765MU2013 2013-11-30 2013-11-30 IN2013MU03765A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3765MU2013 IN2013MU03765A (en) 2013-11-30 2013-11-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3765MU2013 IN2013MU03765A (en) 2013-11-30 2013-11-30

Publications (1)

Publication Number Publication Date
IN2013MU03765A true IN2013MU03765A (en) 2015-07-31

Family

ID=54398014

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3765MU2013 IN2013MU03765A (en) 2013-11-30 2013-11-30

Country Status (1)

Country Link
IN (1) IN2013MU03765A (en)

Similar Documents

Publication Publication Date Title
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
NZ631100A (en) Soft chewable pharmaceutical products
WO2013188792A3 (en) Neuroactive steroids, compositions, and uses thereof
WO2010127345A3 (en) Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
WO2012020131A3 (en) Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2017010280A (en) Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them.
MY178082A (en) Solid pharmaceutical compositions and processes for their production
CY1122626T1 (en) CORTICOSTEROID CONTAINING ORodispersible Tablet Formulations for Eosinophilic Esophagitis
PH12015500823A1 (en) Modified release formulations for oprozomib
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
EP3615011A4 (en) Pharmaceutical composition for in vivo delivery, method of preparation of a substantially waterinsoluble pharmacologically active agent
PH12015500395A1 (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
WO2011083402A3 (en) Immediate release compositions of acid labile drugs
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
MX359436B (en) Pharmaceutical combined preparation containing hmg-coa reductase inhibitor and cholesterol absorption inhibitor.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
MX2015015681A (en) Pharmaceutical composition comprising fingolimod.
IN2013MU03765A (en)
PH12017550051A1 (en) A pharmaceutical composition for treating gastrointestinal diseases
EP4011393A4 (en) Pharmaceutical agent for transmucosal administration
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
WO2014119984A3 (en) Pharmaceutical composition comprising a biphasic immediate-release system for controlling convulsive seizures and pain